HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Reports Selsun Improvement, Builds Ad Spend For Acquired Brands

This article was originally published in The Rose Sheet

Executive Summary

For 2007, Chattem expects sales of products recently acquired from Johnson & Johnson to rival those of its existing "big three" - Gold Bond skin care, Icy Hot topical analgesics and Selsun medicated shampoos

You may also be interested in...



C&D, Chattem Stay Alert For Premium Properties Unloaded From Bigger Firms

Lean and hungry Church & Dwight and Chattem remain ready to pounce on choice morsels that bigger firms may drop from the table, but recognize that too much growth could jeopardize one of their chief competitive advantages

C&D, Chattem Stay Alert For Premium Properties Unloaded From Bigger Firms

Lean and hungry Church & Dwight and Chattem remain ready to pounce on choice morsels that bigger firms may drop from the table, but recognize that too much growth could jeopardize one of their chief competitive advantages

Chattem Boosts Acquired Brands With Ad Spend, Retail Expansion

Chattem's strategy of growing recently acquired brands through aggressive marketing and distribution expansion is paying off, President and COO Robert Bosworth indicated Sept. 5 at the Lehman Brothers Back-to-School Consumer Conference

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel